Foundayo (Orforglipron): Eli Lilly's New Weight Loss Pill — Cost, Dosing & How It Compares

April 9, 2026 · 10 min read

Written by the drug-price.info Editorial Team
Reviewed using FDA-approved drug labels and clinical pharmacology references. Information is for educational purposes only and is not a substitute for professional medical advice.

On April 1, 2026, the FDA approved Foundayo (orforglipron) — the first oral GLP-1 weight loss pill that can be taken any time of day, with or without food, and with no water restrictions. Made by Eli Lilly, it's now available at U.S. pharmacies and through LillyDirect starting at $149/month for self-pay patients.

If you've been following the weight loss drug market, you know the big players — Wegovy, Ozempic, Mounjaro, and Zepbound — are all injectable. Foundayo changes the game: it's a once-daily pill, not a weekly shot. But does it work as well? And what does it actually cost?

The Bottom Line: Foundayo delivers about 12.4% average weight loss (vs. 15-22% for injectables). It costs dramatically less — $149-$349/month self-pay vs. $900-$1,500/month for injectables. For people who want GLP-1 benefits without needles or the price tag of Wegovy/Zepbound, it's a genuine option.

What Is Foundayo?

Foundayo is the brand name for orforglipron, a small molecule GLP-1 receptor agonist made by Eli Lilly. Unlike semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound), which are peptide-based and require injection, orforglipron is a non-peptide molecule that works as a pill.

How it works: Like all GLP-1 drugs, Foundayo mimics the GLP-1 hormone your body releases after eating. It slows stomach emptying, reduces appetite, and helps regulate blood sugar. The result: you eat less and lose weight.

What makes it different:

It's a pill. No needles, no injections, no refrigeration.
No food or water restrictions. The Wegovy pill (oral semaglutide) requires an empty stomach and 30 minutes of fasting with minimal water. Foundayo has none of that — take it anytime.
Once daily. While simpler than daily injections (Saxenda), it's more frequent than weekly shots (Wegovy/Zepbound).
Dramatically cheaper. Starting at $149/month vs. $900+ for injectables.

FDA Approval Details

Approved: April 1, 2026 — the fastest new molecular entity approval since 2002 (50 days from filing).

Indication: Chronic weight management in adults with:

Obesity (BMI ≥ 30), OR
Overweight (BMI ≥ 27) with at least one weight-related condition (hypertension, type 2 diabetes, high cholesterol, cardiovascular disease, obstructive sleep apnea)

Foundayo was approved under the new National Priority Voucher Program, reflecting the public health importance of affordable obesity treatments.

How Much Does Foundayo Cost?

This is where Foundayo really stands out. Eli Lilly priced it aggressively — far below every injectable GLP-1 on the market.

Dose	Self-Pay (LillyDirect)	With Insurance + Savings Card
0.8 mg (starting)	$149/month	As low as $25/month
2.5 mg	$199/month	As low as $25/month
5.5 mg	$299/month	As low as $25/month
9 mg	$299/month	As low as $25/month
14.5 mg	$349/month	As low as $25/month
17.2 mg (highest)	$349/month	As low as $25/month

Medicare Part D: Coverage expected starting July 1, 2026, with estimated costs around $50/month for eligible patients.

Cost Comparison: Foundayo at $149-$349/month is 70-85% cheaper than injectable GLP-1 drugs like Wegovy ($1,300-$1,500/month) and Zepbound ($1,000-$1,200/month) without insurance. Even at its highest dose, Foundayo costs less than any injectable at the lowest dose.

How Effective Is Foundayo?

ATTAIN-1 Clinical Trial Results (72 Weeks)

The FDA approval was based on the ATTAIN-1 trial — a 72-week, randomized, double-blind study in adults with obesity or overweight with at least one weight-related condition (but without diabetes).

Highest dose tested (36 mg in trial): 12.4% average weight loss — about 27 pounds for a 220-pound person. (Note: the FDA-approved dosing tops out at 17.2 mg; higher trial doses informed the efficacy data.)
Placebo group: 0.9% weight loss (about 2 pounds)

That's significant, but it's less than injectable GLP-1 drugs. Here's how Foundayo stacks up:

Drug	Type	Avg Weight Loss	Monthly Cost (No Insurance)
Foundayo	Daily pill	~12%	$149-$349
Wegovy	Weekly injection	~15%	$1,300-$1,500
Zepbound	Weekly injection	~20-22%	$1,000-$1,200
Ozempic	Weekly injection	~10-15%	$900-$1,000
Mounjaro	Weekly injection	~15-20%	$900-$1,100
Saxenda	Daily injection	~5-8%	$1,300-$1,500

Reality Check: Foundayo is less effective than Wegovy and Zepbound for raw weight loss. If maximum weight loss is your top priority and cost isn't an issue, injectable tirzepatide (Zepbound) still delivers the best results at ~20-22%. But for many people, 12% weight loss at a fraction of the cost — without needles — is the better trade-off.

Dosing: How to Take Foundayo

Foundayo uses a gradual dose escalation over several months. You start low and increase every 30 days (or longer) to minimize side effects.

Available doses: 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, 17.2 mg

How to take it:

One tablet by mouth, once daily
Take at any time of day — morning, afternoon, or evening
With or without food
No water restrictions (drink whatever you want)
Swallow whole — do not break, crush, or chew
Wait at least 30 days between dose increases

Not everyone needs the highest dose. Your doctor will find the dose that balances weight loss with side effects. Many patients do well at mid-range doses.

Side Effects

Foundayo's side effects are similar to other GLP-1 drugs. They're mostly GI-related and tend to improve after the first few weeks.

Common Side Effects

Nausea (most common, especially when starting or increasing dose)
Constipation
Diarrhea
Vomiting
Indigestion / heartburn
Stomach pain or bloating
Headache
Fatigue
Gas and belching
Hair loss

Serious Warnings

Boxed Warning — Thyroid C-Cell Tumors: In animal studies, GLP-1 drugs caused thyroid tumors including cancer. It's unknown if this occurs in humans. Do not take Foundayo if you or a family member has had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your doctor about any lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.

Other serious risks:

Pancreatitis: Severe, persistent stomach pain (may radiate to the back) — stop taking and call your doctor immediately
Gallbladder problems: Rapid weight loss increases gallstone risk
Kidney problems: Usually from dehydration caused by vomiting or diarrhea — stay hydrated
Low blood sugar: Risk increases if you also take insulin or sulfonylureas
Allergic reactions: Rash, swelling, difficulty breathing — seek emergency care

Who Can Take Foundayo?

You May Be Eligible If:

You're an adult (18+) with a BMI of 30 or higher (obesity)
You're an adult with a BMI of 27 or higher AND have at least one weight-related condition (high blood pressure, type 2 diabetes, high cholesterol, heart disease, or sleep apnea)

You Should NOT Take Foundayo If:

You or a family member has a history of medullary thyroid cancer (MTC)
You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
You're allergic to orforglipron or any ingredient in Foundayo
You're pregnant or breastfeeding

Where to Get Foundayo

Foundayo became available in the U.S. starting April 6, 2026. You can get it through:

LillyDirect: Eli Lilly's direct-to-patient platform. Prescriptions accepted immediately, shipping started April 6, 2026.
Retail pharmacies: Now available at major U.S. pharmacies nationwide.
Telehealth providers: Many telehealth platforms are prescribing Foundayo.

You'll need a prescription from a licensed healthcare provider. Foundayo is a prescription-only medication — you can't buy it over the counter.

Foundayo vs. Injectable GLP-1 Drugs: Which Should You Choose?

Choose Foundayo If:

You want to avoid needles and injections
Cost is a major factor (especially without insurance)
You tried Wegovy's oral pill but hated the fasting/water restrictions
12% weight loss would be meaningful for your health goals
You prefer the convenience of a daily pill with no dietary restrictions

Choose Injectables (Wegovy/Zepbound) If:

Maximum weight loss is your priority (20%+ with Zepbound)
You have good insurance coverage that makes the cost manageable
You prefer once-weekly dosing over daily pills
You've already tried an oral GLP-1 and didn't get adequate results

Key Differences at a Glance

Feature	Foundayo	Wegovy (Injection)	Zepbound
Form	Daily pill	Weekly injection	Weekly injection
Food restrictions	None	None (injection)	None
Avg weight loss	~12%	~15%	~20-22%
Self-pay cost	$149-$349/mo	$1,300-$1,500/mo	$1,000-$1,200/mo
Mechanism	GLP-1 only	GLP-1 only	GLP-1 + GIP dual
Manufacturer	Eli Lilly	Novo Nordisk	Eli Lilly

What This Means for the Weight Loss Drug Market

Foundayo is a big deal for three reasons:

Price disruption. At $149-$349/month, it undercuts every injectable GLP-1 by 70-85%. This puts pressure on Novo Nordisk (Wegovy/Ozempic) and even Eli Lilly's own Zepbound to compete on price.
Access expansion. Millions of people who couldn't afford $1,000+/month injectables — or whose insurance wouldn't cover them — now have a viable option.
Needle-free. Surveys consistently show that fear of injections is a top reason people avoid GLP-1 drugs. A pill removes that barrier entirely.

The trade-off is clear: you get less weight loss (~12% vs. ~15-22%) but at a fraction of the cost and without injections. For many patients, that's the right deal.

Looking ahead: Eli Lilly is also studying orforglipron for type 2 diabetes (ACHIEVE trials). If approved for diabetes, it could compete directly with Ozempic — at a much lower price point.

Frequently Asked Questions

Is Foundayo the same as Zepbound?

No. Zepbound (tirzepatide) is a weekly injection that targets both GLP-1 and GIP receptors. Foundayo (orforglipron) is a daily pill that targets GLP-1 only. Both are made by Eli Lilly, but they're different drugs with different mechanisms.

Can I switch from Wegovy or Zepbound to Foundayo?

Talk to your doctor. Some patients may prefer switching to save money or avoid injections, but you may see less weight loss. Your doctor can help you weigh the trade-offs.

Does Foundayo require fasting or water restrictions?

No. Unlike the Wegovy pill (oral semaglutide), which requires taking on an empty stomach with minimal water and waiting 30 minutes before eating, Foundayo can be taken at any time with or without food and with no water restrictions.

Will I regain weight if I stop taking Foundayo?

Likely yes. Like all GLP-1 weight loss drugs, the benefits stop when you stop taking the medication. Clinical data from other GLP-1 drugs shows most patients regain weight within 12 months of stopping.

Is Foundayo covered by Medicare?

Not yet. Medicare Part D coverage for Foundayo is expected to begin around July 1, 2026, with estimated costs of about $50/month for eligible patients.

How do I get Foundayo?

You need a prescription from a healthcare provider. You can fill it at retail pharmacies, through telehealth providers, or via LillyDirect (Eli Lilly's direct-to-patient platform).

Related articles:

Medical Disclaimer: This article is for informational purposes only and is based on FDA drug label information and published clinical trial data. Never stop, start, or change medications without consulting your healthcare provider. Weight loss drugs carry risks and are not appropriate for everyone. If you think you may have a medical emergency, call your doctor or 911 immediately. Drug-price.info does not provide medical advice, diagnosis, or treatment.